Back
SPDR® S&P Pharmaceuticals ETF Vs. Invesco Biotechnology & Genome ETF Industry Stock Comparison
Buy
56
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
44.81
Seasonality Move:
-0.34%
Buy
56
PBE
Invesco Biotechnology & Genome ETF
Last Price:
71.19
Seasonality Move:
-0.23%
Buy
56
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $44.87. The Score for XPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Invesco Biotechnology & Genome ETF (PBE)
is a Buy
Is Invesco Biotechnology & Genome ETF a Buy, Sell or Hold?
- The current Invesco Biotechnology & Genome ETF [PBE] share price is $71.35. The Score for PBE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PBE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $44.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
PBE Stock Price Chart
What is Invesco Biotechnology & Genome ETF's stock price today?
-
The Invesco Biotechnology & Genome ETF share price today is $71.35
The current trend is moderately bullish and PBE is experiencing slight selling pressure.
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 61.64 | Buy |
| Chaikin Money Flow: | -18510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.45 - 44.57) | Buy |
| Bollinger Bands (100): | (40.19 - 43.39) | Buy |
PBE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 57.38 | Buy |
| Chaikin Money Flow: | -379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.68 - 71.7) | Buy |
| Bollinger Bands (100): | (64.07 - 70.09) | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.29 | Buy |
| 20-day SMA: | 44.13 | Buy |
| 50-day SMA: | 43.15 | Buy |
| 200-day SMA: | 41.88 | Buy |
| 8-day EMA: | 44.48 | Buy |
| 20-day EMA: | 44.03 | Buy |
| 50-day EMA: | 43.17 | Buy |
| 200-day EMA: | 41.87 | Buy |
PBE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.97 | Buy |
| 20-day SMA: | 70.64 | Buy |
| 50-day SMA: | 69.81 | Buy |
| 200-day SMA: | 65.59 | Buy |
| 8-day EMA: | 71.04 | Buy |
| 20-day EMA: | 70.55 | Buy |
| 50-day EMA: | 69.41 | Buy |
| 200-day EMA: | 65.83 | Buy |
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Invesco Biotechnology & Genome ETF Earnings Growth & PBE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Invesco Biotechnology & Genome ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||